# US 7,608,045 B2 · Method for noninvasive continuous determination of physiologic characteristics

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 7,608,045 B2
- Document ID: US7608045B2
- Status: Granted
- Kind: B2
- Application number: 10/912,721
- Filed: 2004-08-04
- Published: 2005-08-11
- Granted: 2009-10-27
- Earliest claimed: 2001-11-07
- Assignees: Woolsthorpe LLC
- Inventors: Alexander K. Mills
- Web page: https://patentgrep.com/patent/US7608045B2

## CPC

- A61B 5/6826: {Finger}
- A61B 5/02028: {Determining haemodynamic parameters not otherwise provided for, e.g. cardiac contractility or left ventricular ejection fraction}
- A61B 5/0205: Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
- A61B 5/02055: {Simultaneously evaluating both cardiovascular condition and temperature}
- A61B 5/02125: {of pulse wave propagation time}
- A61B 5/0285: Measuring or recording phase velocity of blood waves
- A61B 5/14539: {for measuring pH}
- A61B 5/14546: {for measuring analytes not otherwise provided for, e.g. ions, cytochromes}
- A61B 5/14551: {for measuring blood gases}
- A61B 5/14552: {Details of sensors specially adapted therefor}
- A61B 5/318: Heart-related electrical modalities, e.g. electrocardiography [ECG]
- A61B 5/6838: {Clamps or clips}
- A61B 5/021: Measuring pressure in heart or blood vessels
- A61B 5/029: Measuring blood output from the heart, e.g. minute volume
- A61B 5/14532: {for measuring glucose, e.g. by tissue impedance measurement}
- A61B 2560/0261: using hydrostatic pressure
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

The invention comprises methods for noninvasively monitoring physiological characteristics of a patient's blood. Determinations of blood constituent concentrations may be made by comparing absorbance of radiation at varying parameters, such as path length and blood pressure. Preferably, changes in pressure are effected by changing the height of the probes relative to the patient's heart. Determinations of blood pH may be made by comparing absorbance of the blood at different wavelengths. The temperature of the blood, and thus of the patient's core, may also be accurately determined. Further, cardiac output characteristics and blood pressures may be noninvasively determined using the methods of the invention.

## Claims

### Claim 1

A method for noninvasively determining physiological parameters of a patient, comprising the steps of:
providing a first tissue probe, said first tissue probe including a first radiation emitter adapted to emit first radiation having a first wavelength and a first radiation detector adapted to receive said first radiation after absorbance through a first radiation path length of the patient's blood;
providing a second tissue probe, said second tissue probe including a second radiation emitter adapted to emit second radiation having a second wavelength and a second radiation detector adapted to receive said second radiation after absorbance through a second radiation path length;
varying the volume and pressure of the patient's blood at first and second patient sites, said first patient site being proximate said first tissue probe, said second patient site being proximate second tissue probe;
measuring first absorbance of the patient's blood at said first patient site as said blood volume and pressure are varied by transmitting said first radiation at said first wavelength through the patient's blood and detecting said first radiation after passage through the patient's blood;
measuring second absorbance of the patient's blood at said second patient site as said blood volume and pressure are varied by transmitting said second radiation at said second wavelength through the patient's blood and detecting said second radiation after passage through the patient's blood;
timing the arrival of pulse and flow waves at said first and second patient sites by comparing said first and second absorbances measured at said first and second patient sites; and
determining a cardiac characteristic based on said arrival times of said pulse and flow waves.

### Claim 2 (depends on 1)

The method of claim 1, further comprising the step of measuring the electrical potential of the patient's heart using an electrocardiogram, said electrocardiogram providing an ECG signal, and correlating said timing of said first and second absorbances with said ECG signal.

### Claim 3

A method for non-invasively determining a cardiac characteristic of a patient, comprising the steps of:
determining pulse wave velocity in a first extremity;
determining pulse wave velocity in a second, opposite extremity;
determining flow wave velocity as a function of ratios of said pulse wave velocities in said first and second extremities; and
determining at least one cardiac output characteristic based on said flow wave velocity.

### Claim 4 (depends on 3)

The method of claim 3, wherein said cardiac characteristic is selected from the group comprising cardiac output, cardiac index, cardiac stroke volume, cardiac ejection fraction, and blood volume.

### Claim 5 (depends on 3)

The method of claim 3, wherein said steps of measuring pulse wave velocity in said first and second extremities comprises measuring arrival times of pulse waves in said first and second extremities.

### Claim 6 (depends on 3)

The method of claim 3, further comprising the step of measuring blood pressure and, wherein said flow wave velocity is determined as a function of said blood pressure.

### Claim 7 (depends on 3)

The method of claim 3, wherein the steps of measuring pulse wave velocity in said first and second extremities includes the steps of continuously monitoring oxygen saturation in the patient's blood in said first and second extremities and inducing a change in oxygen saturation in said first and second extremities.

### Claim 8 (depends on 7)

The method of claim 7, wherein said cardiac characteristic is selected from the group comprising cardiac index, cardiac stroke volume and cardiac output, and wherein said cardiac characteristic is computed by determining a time interval between said induced change in oxygen saturation and a first measured change in oxygen saturation.

### Claim 9 (depends on 7)

The method of claim 7, wherein said cardiac characteristic comprises cardiac ejection fraction, and wherein said cardiac ejection fraction is computed by determining the time interval between a first measured change in oxygen saturation and maximal change in oxygen saturation.

### Claim 10 (depends on 7)

The method of claim 7, wherein said cardiac characteristic comprises blood volume, and wherein said blood volume is computed by determining a time interval between said induced change in oxygen saturation and a return to a baseline measured oxygen saturation.